358 related articles for article (PubMed ID: 4572128)
1. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
Wood ML; Heppner G; Gozzo JJ; Monaco AP
Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
[No Abstract] [Full Text] [Related]
2. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Gozzo JJ; Wood ML; Pompei R; Monaco AP
Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
[No Abstract] [Full Text] [Related]
3. Active enhancement of tissue allografts with antilymphocyte serum and bone marrow.
Monaco AP; Liegeois A; Wood ML; Clark AW
Adv Nephrol Necker Hosp; 1975; 5():135-72. PubMed ID: 242206
[No Abstract] [Full Text] [Related]
4. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
Monaco AP; Wood ML
Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
[No Abstract] [Full Text] [Related]
5. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
Hellström I; Hellström KE
Johns Hopkins Med J Suppl; 1974; 3():301-5. PubMed ID: 4607384
[No Abstract] [Full Text] [Related]
6. Fractionated bone marrow: use of a lymphocyte containing fraction for skin allograft prolongation in antilymphocyte serum (ALS) treated mice.
Gozzo JJ; Litvin DA; Bhatnagar YM; Monaco AP
Transplant Proc; 1981 Mar; 13(1 Pt 1):592-5. PubMed ID: 7022895
[No Abstract] [Full Text] [Related]
7. Conditioning recipients of hemopoietic cells with antilymphocytic serum (ALS) and partial-body irradiation.
Kolb H; Thierfelder S; Baumann P; Balk O
Rev Eur Etud Clin Biol; 1971 Oct; 16(8):810-4. PubMed ID: 4399647
[No Abstract] [Full Text] [Related]
8. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
Bobbio SA; Wood ML; Monaco AP
Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
[No Abstract] [Full Text] [Related]
9. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
Brochier J; Fries D
Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
[No Abstract] [Full Text] [Related]
10. Cell-mediated immunity and serum blocking factor in tolerance produced in mice with antilymphocyte serum and bone marrow cell infusion.
Wood ML; Gozzo JJ; Heppner G; Monaco AP
Transplant Proc; 1972 Sep; 4(3):383-9. PubMed ID: 4263511
[No Abstract] [Full Text] [Related]
11. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
Wood ML; Gozzo JJ; Monaco AP
Transplant Proc; 1972 Dec; 4(4):523-9. PubMed ID: 4405146
[No Abstract] [Full Text] [Related]
12. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
[No Abstract] [Full Text] [Related]
13. Time-dependence of ALS effects on immunological and haematopoietic activities in mice.
Nouza K; Haskovcová H; Nĕmec M
Folia Biol (Praha); 1971; 17(5):312-21. PubMed ID: 4399318
[No Abstract] [Full Text] [Related]
14. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
Wood ML; Monaco AP
Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
[No Abstract] [Full Text] [Related]
15. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
Monaco AP; Gozzo JJ; Wood ML; Liegeois A
Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
[No Abstract] [Full Text] [Related]
16. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
Caridis DT; Liegeois A; Barrett I; Monaco AP
Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
[No Abstract] [Full Text] [Related]
17. Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.
Auchincloss H; Ghobrial RR; Shea S; Pierson RN; Winn HJ
Transplant Proc; 1988 Dec; 20(6):1190-3. PubMed ID: 3059601
[No Abstract] [Full Text] [Related]
18. The effects of phytohemagglutinin and antilymphocyte globulin in inducing immunosuppression and tolerance in mice.
Moore CD; Slavin RG
Transplantation; 1971 Jun; 11(6):563-6. PubMed ID: 4931456
[No Abstract] [Full Text] [Related]
19. Augmentation by donor bone marrow of the survival of neonatal skin transplants to ALS-treated recipients.
Gozzo JJ; Kowolenko M
Transplant Proc; 1987 Feb; 19(1 Pt 1):470-1. PubMed ID: 3274809
[No Abstract] [Full Text] [Related]
20. The effect of heterologous antilymphocyte serum on the formation of H-2 antibody and the induction of allograft immunity.
Monaco AP; Franco DJ
Transplant Proc; 1969 Mar; 1(1):474-8. PubMed ID: 4944263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
